Research Papers

25 of 519 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Triglyceride-Glucose Index Predicts Future Atherosclerotic Cardiovascular Diseases: A 16-Year Follow-up in a Prospectiv…
Moon JH; Kim Y; Oh TJ; Moon JH; Kwak SH; Park KS; Jang HC; Choi SH; Cho NH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Intrarenal Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors on Tubuloglomerular Feedback and Natriuresis.
Koh ES; Kim GH; Chung S.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Risk of Pancreatic Cancer and Use of Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes: A Propensity S…
Kim MK; Han K; Kwon HS; Yoo SJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Greater Severity of Steatosis Is Associated with a Higher Risk of Incident Diabetes: A Retrospective Longitudinal Study.
Han JM; Cho JH; Kim HI; Suh S; Lee YJ; Lee JW; Kim KM; Bae JC.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Efficacy of Gemigliptin Add-on to Dapagliflozin and Metformin in Type 2 Diabetes Patients: A Randomized, Double-Blind, …
Lee BW; Min K; Hong EG; Ku BJ; Kang JG; Chon S; Lee WY; Park MK; Kim JH; Kim SY; Song K; Yoo SJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Thyroid Hormone Reference Intervals among Healthy Individuals In Lanzhou, China.
Lu Y; Zhang WX; Li DH; Wei LH; Zhang YJ; Shi FN; Zhou S.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognos…
Yu J; Baek HS; Jeong C; Jo K; Lee J; Ha J; Kim MH; Lee J; Lim DJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Association between Serum Amyloid A Levels and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Liu T; Li M; Cui C; Zhou J.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Registered
Corrigendum: Abstract and Text Correction. Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfun…
Kim WG; Kim WB; Woo G; Kim H; Cho Y; Kim TY; Kim SW; Shin MH; Park JW; Park HL; Oh K; Chung JH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
1/6 Transparent
Corrigendum: Affiliation Correction. Development and Validation of a Risk Scoring System Derived from Meta-Analyses for…
Suh S; Goh TS; Kim YH; Oh SO; Pak K; Seok JW; Kim IJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
1/6 Transparent
Inhibition of Fatty Acid β-Oxidation by Fatty Acid Binding Protein 4 Induces Ferroptosis in HK2 Cells Under High Glucos…
Chen J; Wu K; Lei Y; Huang M; Cheng L; Guan H; Lin J; Zhong M; Wang X; Zheng Z.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
New Insights into Calorie Restriction Induced Bone Loss.
Liu L; Rosen CJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study.
Choi JH; Kim KM; Song K; Seo GH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Brown Adipose Tissue: Activation and Metabolism in Humans.
Hachemi I; U-Din M.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association between N-Terminal Prohormone Brain Natriuretic Peptide and Decreased Skeletal Muscle Mass in a Healthy Adu…
Yoo TK; Wu MY; Kim MS; Lee MY; Lee YT; Yoon KJ; Park CH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes.
Chung SM; Kang MK; Moon JS; Park JG.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Positive Vasculitis and Agranulocytosis: A Rare Case with …
Kang DH; Song MK; Ju SH; Lee SI; Kang YE.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Lower Thyroid Cancer Mortality in Patients Detected by Screening: A Meta-Analysis.
Moon S; Song YS; Jung KY; Lee EK; Park YJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Survival Comparison of Incidentally Found versus Clinically Detected Thyroid Cancers: An Analysis of a Nationwide Cohor…
Moon S; Lee EK; Choi H; Park SK; Park YJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease.
Kim DL; Lee SE; Kim NH.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Cardiovascular Impact of Calcium and Vitamin D Supplements: A Narrative Review.
Zarzour F; Didi A; Almohaya M; Kendler D.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Overcoming Therapeutic Inertia as the Achilles' Heel for Improving Suboptimal Diabetes Care: An Integrative Review.
Chew BH; Mohd-Yusof BN; Lai PSM; Khunti K.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent
Incretin and Pancreatic β-Cell Function in Patients with Type 2 Diabetes.
Ahn CH; Oh TJ; Min SH; Cho YM.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Impact of Post-Transplant Diabetes Mellitus on Survival and Cardiovascular Events in Kidney Transplant Recipients.
Jeon JY; Han-Bit S; Park BH; Lee N; Kim HJ; Kim DJ; Lee KW; Han SJ.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and Beyond.
Viljoen A; Bain SC.
Endocrinol Metab (Seoul) (Unknown)
Published: 2023
2/6 Transparent